FDA Inspection
IndeCon, Inc.IndeCon, Inc. – FDA Inspection, May 29, 2014
Record Details
This FDA Inspection record concerns IndeCon, Inc., with an inspection on May 29, 2014, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- IndeCon, Inc.
- Inspection Date
- May 29, 2014
- Product Type
- Biologics
View Company Profile
ID · d7e6e7b4-204c-4ccf-939f-20039f8ce5e7
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 880573
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
FDA Citations
3- 21 CFR 1271.265(e)Documentation elements for activities
- 21 CFR 1271.265(e)Procedures and release criteria
- 21 CFR 1271.260(e)Storage temperatures recorded, maintained
Full citation text and observation details available on the Dashboard.
Other FDA inspections of IndeCon, Inc.
2| Date | Classification | Office | Project area |
|---|---|---|---|
| December 12, 2024 | VAI | Dallas District Office | Human Cellular, Tissue, and Gene Therapies |
| November 22, 2016 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for IndeCon, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.